View full directory A–Z

Gene Target: HTT

Huntington's Disease CAG Repeat Analysis

Huntington's disease is an autosomal dominant neurodegenerative disorder caused by an expanded CAG trinucleotide repeat in the HTT gene on chromosome 4.


Indications: Why test HTT?

  • Diagnostic confirmation in individuals presenting with progressive chorea, cognitive decline, or psychiatric changes.
  • Predictive genetic testing for adults with a confirmed family history of Huntington’s Disease.

When should I take the test? When clinical symptoms appear or as part of structured predictive testing following formal counseling.

Do I need to fast or prepare? Genetic counseling is required prior to testing.

Test Summary Specs

Turnaround Time 10 to 14 Business Days
Estimated Cost KES 32,000 – KES 42,000
Methodology Targeted PCR / Sanger / NGS Variant Panel
Sample Type 5 mL Peripheral Whole Blood (EDTA), Buccal Swabs, or Prenatal Samples
Clinical Use Diagnostic Confirmation, Carrier Screening, Reproductive Risk Assessment
-->